Glucose Metabolism Disorders
124 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Metabolic Diseases
Narrower: Diabetes Mellitus 94, Diabetes Mellitus, Type 2 72, Glucose Intolerance 2, Hyperglycemia 3, Hypoglycemia 5, Insulin Resistance 21, Metabolic Syndrome 12, Prediabetic State 6
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| AI-Guided Multimodal Rehabilitation Program for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Aminohippurate Sodium Inj 20% + CANAGLIFLOZIN for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ARBs in combination of SGLT2i for diabetes mellitus | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ATR-258 for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Avexitide for glucose metabolism disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Avexitide for hypoglycemia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| AZD6234 for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Berberine ursodeoxycholate for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 6 |
| Berobenatide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Beta glucan for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bread with added beta-glucans for hyperglycemia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bread with added beta-glucans for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cagrilintide for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Calorie restricted diet and exercise intervention for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Calorie restriction via total food replacement for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| cfMSC therapy for diabetes for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| cfMSC therapy for diabetes for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| CIL001 (Paliroden) for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clazakizumab for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clofutriben for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Continous Glucose Monitor (CGM) + Low-calorie diet + Personalized exercise program for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Control for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Culturally Tailored Diabetes Prevention Program for prediabetic state | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Culturally Tailored Diabetes Prevention Program + Culturally Tailored DPP Enhanced with Socioeconomic Supports for prediabetic state | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Danuglipron for diabetes mellitus | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dapagliflozin for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dapagliflozin + Elecoglipron for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| delayed APM group recruit participants with symptoms lasting for more than 6 months for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexcom G6 Professional Continuous Glucose Monitor + INSULIN HUMAN for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexcom G6 Professional Continuous Glucose Monitor + Sliding Scale Insulin for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexcom G6 Professional Continuous Glucose Monitor + Up-Titration of Home Insulin for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Diet-as-Usual (DAU) + LCHF Ketogenic Diet for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Digital Intervention + Metformin for prediabetic state | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| digital prosthetic interface technology for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DMR Procedure for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DMR Procedure (Fractyl) for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dulaglutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Early arthroscopic partial menisectomy group for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Elecoglipron for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| Eloralintide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| Eloralintide + Macupatide for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| eloralintide and tirzepatide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Empagliflozin for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Empagliflozin for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Exercise for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Exploratory test group for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ezetimibe or ezetimibe-statin combination therapy for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| fecal microbiota transplantation from healthy lean donors for metabolic syndrome | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fixed-Dose Combination Strategy for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Food Security Screening & Referral Program for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Food-based diet for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Formula diet for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Green coffee + beta-glucan for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Green coffee extract for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HD-6277 100mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HD-6277 25mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HD-6277 50mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| High-dose LC-Z300-01 twice daily in blinding for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| High-intensity Mediterranean diet intervention for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HS-20094 Injection for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hyperpolarized 13C-pyruvate for metabolic syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| icovamenib 100 mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| icovamenib 100mg for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Insulin efsitora alfa for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 12 |
| Insulin efsitora alfa for insulin resistance | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intensified medical follow-up and glucose-lowering drugs for prediabetic state | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intensive lifestyle Intervention for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intensive lifestyle Intervention + Meal replacement system for diabetes mellitus, type 2 | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intermittent energy restriction (IER) for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intermittent fasting 5:2 + Low-carbohydrate diet + Total diet replacement for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| K-757 and K-833 for diabetes mellitus, type 2 | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| K-757 and K-833 BID + K-757 and K-833 QD for diabetes mellitus, type 2 | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic Diet for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic Diet for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| libitum diet and waiting list control group for metabolic syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Liraglutide for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Low-calorie MIND-HK diet for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Low-dose LC-Z300-01 twice daily in blinding for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Macupatide for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Maridebart Cafraglutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Metreleptin for insulin resistance | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| MiniMed 670G system for hypoglycemia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| MKP10241 for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Neovasculgen® for diabetes mellitus | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oral appliance therapy for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Orforglipron for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 15 |
| Oxytocin for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment. for metabolic syndrome | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PF-08653944 for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PG-102 for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Phentermine / Topiramate Oral Product for glucose intolerance | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PolyPill for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Relacorilant for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Relacorilant for insulin resistance | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for diabetes mellitus | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 10 |
| Retatrutide for insulin resistance | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for diabetes mellitus | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 7 |
| Semaglutide for glucose intolerance | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for prediabetic state | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Semaglutide + Cagrilintide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Sernova Cell Pouch for hypoglycemia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Structured weight-loss program for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Survodutide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Test group for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tifeglipron for diabetes mellitus, type 2 | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Time Restricted Eating (TRE) for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Time Restricted Eating As Treatment (TREAT) for Diabetes. for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Time restricted feeding for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Time-restricted eating for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for diabetes mellitus | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 5 |
| Tirzepatide for metabolic syndrome | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Tirzepatide for prediabetic state | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Total Diet Replacement for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Total Diet Replacement (800kcal/day) for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Total Diet Replacement (TDR) Program for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Very Low-calorie MIND-HK diet for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vicadrostat for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vitamin D supplementation for diabetes mellitus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VX-017 for hypoglycemia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Zenagamtide for diabetes mellitus, type 2 | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Zimislecel for hypoglycemia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.